Clinical Trial Update: Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of ZP4207 Compared to a Comparator [Phase 1]

View source ↗

Summary

Phase 1 single-ascending-dose study of ZP4207 in healthy volunteers and type 1 diabetes patients to evaluate safety, tolerability, pharmacokinetics and pharmaco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• ZP4207

Snippet

Sponsor: Zealand Pharma | Conditions: Hypoglycemia | Phase 1 | Status: COMPLETED